These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 3656100

  • 1. Fluorescence energy transfer study of the relationship between the lone tryptophan residue and drug binding sites in human serum albumin.
    Kasai S, Horie T, Mizuma T, Awazu S.
    J Pharm Sci; 1987 May; 76(5):387-92. PubMed ID: 3656100
    [Abstract] [Full Text] [Related]

  • 2. Drug binding properties of glycosylated human serum albumin as measured by fluorescence and circular dichroism.
    Okabe N, Hashizume N.
    Biol Pharm Bull; 1994 Jan; 17(1):16-21. PubMed ID: 8148809
    [Abstract] [Full Text] [Related]

  • 3. Monoacylglycerol binding to human serum albumin: evidence that monooleoylglycerol binds at the dansylsarcosine site.
    Thumser AE, Buckland AG, Wilton DC.
    J Lipid Res; 1998 May; 39(5):1033-8. PubMed ID: 9610770
    [Abstract] [Full Text] [Related]

  • 4. Participation of the lone tryptophan residue of rat alpha-foetoprotein in its drug-binding sites. Comparison with rat serum albumin.
    Hervé F, Martin MT, Rajkowski K, Dessen P, Cittanova N.
    Biochem J; 1987 May 15; 244(1):81-5. PubMed ID: 2444212
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Inhibitory effects of amino-acid fluids on drug binding to site II of human serum albumin in vitro.
    Yamasaki K, Kuga N, Takamura N, Furuya Y, Hidaka M, Iwakiri T, Nishii R, Okumura M, Kodama H, Kawai K, Arimori K.
    Biol Pharm Bull; 2005 Mar 15; 28(3):549-52. PubMed ID: 15744089
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. 7-Alkylaminocoumarin-4-acetic acids as fluorescent probe for studies of drug-binding sites on human serum albumin.
    Irikura M, Takadate A, Goya S, Otagiri M.
    Chem Pharm Bull (Tokyo); 1991 Mar 15; 39(3):724-8. PubMed ID: 2070455
    [Abstract] [Full Text] [Related]

  • 11. A comparison of drug binding sites on mammalian albumins.
    Panjehshahin MR, Yates MS, Bowmer CJ.
    Biochem Pharmacol; 1992 Sep 01; 44(5):873-9. PubMed ID: 1382424
    [Abstract] [Full Text] [Related]

  • 12. Characterization of the aflatoxin B1-binding site of rat albumin.
    Dirr HW, Schabort JC.
    Biochim Biophys Acta; 1987 Jul 07; 913(3):300-7. PubMed ID: 3109487
    [Abstract] [Full Text] [Related]

  • 13. Effect of valproic acid, its unsaturated metabolites and some structurally related fatty acids on the binding of warfarin and dansylsarcosine to human albumin.
    Panjehshahin MR, Bowmer CJ, Yates MS.
    Biochem Pharmacol; 1991 Apr 15; 41(8):1227-33. PubMed ID: 1706921
    [Abstract] [Full Text] [Related]

  • 14. Structure of pressure-induced denatured state of human serum albumin: a comparison with the intermediate in urea-induced denaturation.
    Tanaka N, Nishizawa H, Kunugi S.
    Biochim Biophys Acta; 1997 Mar 07; 1338(1):13-20. PubMed ID: 9074611
    [Abstract] [Full Text] [Related]

  • 15. Interaction of kaempferol with human serum albumin: a fluorescence and circular dichroism study.
    Matei I, Hillebrand M.
    J Pharm Biomed Anal; 2010 Feb 05; 51(3):768-73. PubMed ID: 19853398
    [Abstract] [Full Text] [Related]

  • 16. Determination of the affinity of drugs toward serum albumin by measurement of the quenching of the intrinsic tryptophan fluorescence of the protein.
    Epps DE, Raub TJ, Caiolfa V, Chiari A, Zamai M.
    J Pharm Pharmacol; 1999 Jan 05; 51(1):41-8. PubMed ID: 10197416
    [Abstract] [Full Text] [Related]

  • 17. Five recombinant fragments of human serum albumin-tools for the characterization of the warfarin binding site.
    Dockal M, Chang M, Carter DC, Rüker F.
    Protein Sci; 2000 Aug 05; 9(8):1455-65. PubMed ID: 10975567
    [Abstract] [Full Text] [Related]

  • 18. Ligand binding at membrane mimetic interfaces. Human serum albumin in reverse micelles.
    Desfosses B, Cittanova N, Urbach W, Waks M.
    Eur J Biochem; 1991 Jul 01; 199(1):79-87. PubMed ID: 1712302
    [Abstract] [Full Text] [Related]

  • 19. Interactions of human serum albumin with meloxicam: characterization of binding site.
    Trynda-Lemiesz L, Wiglusz K.
    J Pharm Biomed Anal; 2010 Jun 05; 52(2):300-4. PubMed ID: 20089378
    [Abstract] [Full Text] [Related]

  • 20. Fluorescence study on site-specific binding of perfluoroalkyl acids to human serum albumin.
    Chen YM, Guo LH.
    Arch Toxicol; 2009 Mar 05; 83(3):255-61. PubMed ID: 18854981
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.